William Wesemann Biography and Net Worth

Director of Aclarion

Mr. Wesemann has been on the Aclarion Board of Directors since 2016. Mr. Wesemann has been an independent businessman and investor since June 2002. Prior to 2002 his experience included serving in chief executive, sales leadership, and advisory roles at various technology companies. He has been a director of LivePerson (Nasdaq: LPSN), a global technology company that develops conversational commerce and AI software. He is also a director of Stationhead, Inc., a consumer social audio platform; and a director of Mylio, Inc, a photo management company. Mr. Wesemann received a B.A. from Glassboro State College (Rowan University).

What is William Wesemann's net worth?: The estimated net worth of William Wesemann is at least $56.13 thousand as of August 13th, 2026. Mr. Wesemann owns 23,713 shares of Aclarion stock worth more than $56,129 as of October 8th. This net worth estimate does not reflect any other assets that Mr. Wesemann may own. Learn More about William Wesemann's net worth.
How do I contact William Wesemann?: The corporate mailing address for Mr. Wesemann and other Aclarion executives is 8181 Arista Place, Ste 100, Broomfield, CO, 80021. Aclarion can also be reached via phone at 833-275-2266. Learn More on William Wesemann's contact information.
Has William Wesemann been buying or selling shares of Aclarion?: William Wesemann has not been actively trading shares of Aclarion during the last ninety days. Most recently, on Thursday, August 13th, William Wesemann bought 2,150 shares of Aclarion stock. The stock was acquired at an average cost of $2.34 per share, with a total value of $5,031.00. Following the completion of the transaction, the director now directly owns 23,713 shares of the company's stock, valued at $55,488.42. Learn More on William Wesemann's trading history.
Who are Aclarion's active insiders?: Aclarion's insider roster includes Ryan Bond (Chief Strategy Officer), Scott Breidbart (Director), Gregory Gould (CFO), Gregory Gould (CFO), David Neal (Director), Brent Ness (CEO), Brent Ness (Chief Executive Officer, President, and Director), William Wesemann (Director), and Amanda Williams (Director). Learn More on Aclarion's active insiders.
Are insiders buying or selling shares of Aclarion?: During the last twelve months, Aclarion insiders bought shares 11 times. They purchased a total of 67,888 shares worth more than $176,647.43. The most recent insider tranaction occured on August, 17th when Director Amanda M Williams bought 5,857 shares worth more than $15,989.61. Insiders at Aclarion own 0.0% of the company. Learn More about insider trades at Aclarion.
Information on this page was last updated on 8/17/2026.

William Wesemann Insider Trading History at Aclarion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/13/2026	Buy	2,150	$2.34	$5,031.00	23,713
5/6/2026	Buy	1,562	$3.30	$5,154.60	1,563

William Wesemann Buying and Selling Activity at Aclarion

Aclarion Company Overview

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Today's Range

Now: $2.35

$2.32

$2.41

50 Day Range

MA: $2.46

$2.02

$2.94

2 Week Range

Now: $2.35

$1.95

$12.03

Volume

21,449 shs

Average Volume

325,158 shs

Market Capitalization

$6.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2